← FDA Drug Approvals (Drugs@FDA)

INCRUSE ELLIPTA

NDA · New Drug Application · Sponsor: GLAXO GRP ENGLAND · Approved 2014-04-30

Drug application

FDA Application #

NDA205382

Application type

New Drug Application

Brand name

INCRUSE ELLIPTA

Generic name

UMECLIDINIUM

Active ingredients

UMECLIDINIUM BROMIDE

Dosage form

POWDER

Route

INHALATION

Marketing status

Prescription

Sponsor

GLAXO GRP ENGLAND

Manufacturer

Prasco Laboratories

First approval

2014-04-30

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown